Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.

Literature DB >> 26139648

Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.

Luca Marchetto¹, Desiree Sordino², Giuseppe De Bernardo³, Daniele Trevisanuto¹.

Abstract

Maternal hypertensive treatment with angiotensin receptor blockers (ARBs) during the second and third trimester of pregnancy is associated with several fetal and neonatal complications, and potential adverse outcomes. We report a neonate presenting with transient renal acute failure during the first days of life after maternal treatment with ARBs. Women who became pregnant while taking one of these drugs must modify antihypertensive therapy with a different class drug as soon as pregnancy is recognised. 2015 BMJ Publishing Group Ltd.

Entities: Disease Species

Mesh：

Substances：

Year: 2015 PMID： 26139648 PMCID： PMC4493225 DOI： 10.1136/bcr-2014-207450

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

Keyword Cloud
References

19 in total

1. Angiotensin II receptor blocker induced fetopathy: 7 cases.

Authors: C Hünseler; A Paneitz; D Friedrich; U Lindner; A Oberthuer; F Körber; K Schmitt; L Welzing; A Müller; P Herkenrath; B Hoppe; L Gortner; B Roth; E Kattner; T Schaible
Journal: Klin Padiatr Date: 2011-01-26 Impact factor: 1.349

2. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy.

Authors: R M Cox; J M Anderson; P Cox
Journal: BJOG Date: 2003-11 Impact factor: 6.531

3. Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

Authors: Marc Oppermann; Stephanie Padberg; Angela Kayser; Corinna Weber-Schoendorfer; Christof Schaefer
Journal: Br J Clin Pharmacol Date: 2013-03 Impact factor: 4.335

Review 4. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

Authors: Janine E Polifka
Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-07-17

Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.

1. Angiotensin II receptor blocker induced fetopathy: 7 cases.

2. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy.

3. Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

Review 4. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

5. Losartan and fetal toxic effects.

Review 6. Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension.

7. Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.

8. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.

Review 9. The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.

10. Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker.